|
| 36303436 | Self-amplifying RNA vaccine protects mice against lethal Ebola virus infection. | Mol Ther | 2023 |
| 38001893 | SARS-CoV-2 and Epstein-Barr Virus-like Particles Associate and Fuse with Extracellular Vesicles in Virus Neutralization Tests. | Biomedicines | 2023 |
| 37392738 | The C-terminus of Sudan ebolavirus VP40 contains a functionally important CX<sub>n</sub>C motif, a target for redox modifications. | Structure | 2023 |
| 37112806 | Inhibition of Rab1B Impairs Trafficking and Maturation of SARS-CoV-2 Spike Protein. | Viruses | 2023 |
| 37243266 | Short- and Long-Interval Prime-Boost Vaccination with the Candidate Vaccines MVA-SARS-2-ST and MVA-SARS-2-S Induces Comparable Humoral and Cell-Mediated Immunity in Mice. | Viruses | 2023 |
| 35167409 | Cyclosporin A Reveals Potent Antiviral Effects in Preclinical Models of SARS-CoV-2 Infection. | Am J Respir Crit Care Med | 2022 |
| 35853863 | Increased neutralization and IgG epitope identification after MVA-MERS-S booster vaccination against Middle East respiratory syndrome. | Nat Commun | 2022 |
| 35455282 | Protective CD8+ T Cell Response Induced by Modified Vaccinia Virus Ankara Delivering Ebola Virus Nucleoprotein. | Vaccines (Basel) | 2022 |
| 36680162 | Ebola Virus Activates IRE1α-Dependent <i>XBP1u</i> Splicing. | Viruses | 2022 |
| 36179320 | Diastereomeric Resolution Yields Highly Potent Inhibitor of SARS-CoV-2 Main Protease. | J Med Chem | 2022 |
| 35900983 | Assembly and transport of filovirus nucleocapsids. | PLoS Pathog | 2022 |
| 36301637 | Stabilized recombinant SARS-CoV-2 spike antigen enhances vaccine immunogenicity and protective capacity. | J Clin Invest | 2022 |
| 36382127 | Quantitation of SARS-CoV-2 neutralizing antibodies with a virus-free, authentic test. | PNAS Nexus | 2022 |
| 36227853 | An introduction to the Marburg virus vaccine consortium, MARVAC. | PLoS Pathog | 2022 |
| 35224466 | No substantial preexisting B cell immunity against SARS-CoV-2 in healthy adults. | iScience | 2022 |
| 35110370 | Proteomic landscape of SARS-CoV-2- and MERS-CoV-infected primary human renal epithelial cells. | Life Sci Alliance | 2022 |
| 32882148 | RNA secondary structure at the transcription start site influences EBOV transcription initiation and replication in a length- and stability-dependent manner. | RNA Biol | 2021 |
| 33817572 | The sphingosine kinase 1 activator, K6PC-5, attenuates Ebola virus infection. | iScience | 2021 |
| 34699554 | Identification and characterization of short leader and trailer RNAs synthesized by the Ebola virus RNA polymerase. | PLoS Pathog | 2021 |
| 34545074 | Multi-level inhibition of coronavirus replication by chemical ER stress. | Nat Commun | 2021 |
| 34452363 | Intranasal Administration of a Monoclonal Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection. | Viruses | 2021 |
| 34260076 | Non-canonical proline-tyrosine interactions with multiple host proteins regulate Ebola virus infection. | EMBO J | 2021 |
| 34162739 | Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination. | Proc Natl Acad Sci U S A | 2021 |
| 33268520 | Regulation of VP30-Dependent Transcription by RNA Sequence and Structure in the Genomic Ebola Virus Promoter. | J Virol | 2021 |
| 33412174 | Development and characterization of an indirect ELISA to detect SARS-CoV-2 spike protein-specific antibodies. | J Immunol Methods | 2021 |
| 33065039 | Longitudinal antibody and T cell responses in Ebola virus disease survivors and contacts: an observational cohort study. | Lancet Infect Dis | 2021 |
| 31603201 | Randomized, Blinded, Dose-Ranging Trial of an Ebola Virus Glycoprotein Nanoparticle Vaccine With Matrix-M Adjuvant in Healthy Adults. | J Infect Dis | 2020 |
| 31784751 | Postexposure Prophylaxis With rVSV-ZEBOV Following Exposure to a Patient With Ebola Virus Disease Relapse in the United Kingdom: An Operational, Safety, and Immunogenicity Report. | Clin Infect Dis | 2020 |
| 31924730 | Hexamer phasing governs transcription initiation in the 3'-leader of Ebola virus. | RNA | 2020 |
| 32098814 | Serine-Arginine Protein Kinase 1 Regulates Ebola Virus Transcription. | mBio | 2020 |
| 32102881 | The Integrity of the YxxL Motif of Ebola Virus VP24 Is Important for the Transport of Nucleocapsid-Like Structures and for the Regulation of Viral RNA Synthesis. | J Virol | 2020 |
| 32946786 | Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients. | Cell | 2020 |
| 32802410 | Adjuvant formulated virus-like particles expressing native-like forms of the Lassa virus envelope surface glycoprotein are immunogenic and induce antibodies with broadly neutralizing activity. | NPJ Vaccines | 2020 |
| 32734855 | Duration of SARS-CoV-2 RNA detection in COVID-19 patients in home isolation, Rhineland-Palatinate, Germany, 2020 - an interval-censored survival analysis. | Euro Surveill | 2020 |
| 32707734 | Ebola Virus Nucleocapsid-Like Structures Utilize Arp2/3 Signaling for Intracellular Long-Distance Transport. | Cells | 2020 |
| 33016878 | Ebola and Marburg virus matrix layers are locally ordered assemblies of VP40 dimers. | Elife | 2020 |
| 32702298 | Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial. | Lancet | 2020 |
| 32616594 | Cyclophilin inhibitors restrict Middle East respiratory syndrome coronavirus <i>via</i> interferon-λ <i>in vitro</i> and in mice. | Eur Respir J | 2020 |
| 32499066 | Humoral and cellular immune response induced by rVSVοG-ZEBOV-GP vaccine among frontline workers during the 2013-2016 West Africa Ebola outbreak in Guinea. | Vaccine | 2020 |
| 32463974 | Epitopes of Naturally Acquired and Vaccine-Induced Anti-Ebola Virus Glycoprotein Antibodies in Single Amino Acid Resolution. | Biotechnol J | 2020 |
| 32325038 | Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial. | Lancet Infect Dis | 2020 |
| 32325037 | Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trial. | Lancet Infect Dis | 2020 |
| 32198291 | Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors. | Science | 2020 |
| 30452666 | Detectable Vesicular Stomatitis Virus (VSV)-Specific Humoral and Cellular Immune Responses Following VSV-Ebola Virus Vaccination in Humans. | J Infect Dis | 2019 |
| 31705137 | Humoral Immunogenicity and Efficacy of a Single Dose of ChAdOx1 MERS Vaccine Candidate in Dromedary Camels. | Sci Rep | 2019 |
| 30114391 | Development and characterization of DNAzyme candidates demonstrating significant efficiency against human rhinoviruses. | J Allergy Clin Immunol | 2019 |
| 31495285 | Marburg virus regulates the IRE1/XBP1-dependent unfolded protein response to ensure efficient viral replication. | Emerg Microbes Infect | 2019 |
| 31591605 | Polyclonal and convergent antibody response to Ebola virus vaccine rVSV-ZEBOV. | Nat Med | 2019 |
| 31125846 | Anti-Niemann Pick C1 Single-Stranded Oligonucleotides with Locked Nucleic Acids Potently Reduce Ebola Virus Infection In Vitro. | Mol Ther Nucleic Acids | 2019 |
| 30893855 | Characterization of the Filovirus-Resistant Cell Line SH-SY5Y Reveals Redundant Role of Cell Surface Entry Factors. | Viruses | 2019 |